MCM9 and hypogonadism: We recommend considering biallelic MCM9 variants in individuals and families with unexplained polyposis, gastric cancer, germ cell tumors, or (early-onset) CRC, particularly in cases of recessive inheritance and known hypogonadism, until more data are available.